Lucy Therapeutics
PrivateLast Round
Grant
May 28, 2024
Total Funding Raised
$25.94M
Company Overview
Lucy Therapeutics operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a Grant round in May 2024.
Lucy Therapeutics is a biotechnology company that develops proprietary mitochondrial-based small molecule therapies and diagnostic biomarkers for complex neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lucy Therapeutics Comparables
Compare Lucy Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vincere Biosciences | 88% | |
| Mitochon Pharmaceuticals | 87% | |
| Acurex Biosciences | 87% |
For institutional investors. Book with your work email.
Lucy Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 28, 2024 | ||||
| VC Round | May 28, 2024 | ||||
| Grant | Oct 11, 2023 | ||||
| Grant | Apr 11, 2022 | ||||
| Series A | Jan 6, 2022 | ||||
Seed | Jun 28, 2019 |
For institutional investors. Book with your work email.
Lucy Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Engine Ventures | Series A, Seed, Grant |
| Parkinson's UK | VC Round, Grant |
| International Rett Syndrome Foundation | Grant |
| Massachusetts Life Sciences Center | Series A |
| Safar Partners | Series A, VC Round, Seed, Grant |
| The Michael J. Fox Foundation for Parkinson's Research | VC Round, Grant |
| Engine Ventures | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors increased 154% MoM, reaching 960.
- May 28, 2024
$2M round led by Engine Ventures and Safar Partners.
For institutional investors. Book with your work email.
Lucy Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lucy Therapeutics's valuation, stock price, and market status.
Is Lucy Therapeutics a public or private company?
Lucy Therapeutics is a private company.
What is the current stock price of Lucy Therapeutics?
Lucy Therapeutics is a private company, so its shares have no public market price. Caplight tracks Lucy Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lucy Therapeutics worth (valuation)?
Valuation information for Lucy Therapeutics is not publicly available.
Can I buy Lucy Therapeutics stock?
Lucy Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lucy Therapeutics's last funding round?
Lucy Therapeutics's most recent funding round was Grant on May 28, 2024.
Who are the main investors in Lucy Therapeutics?
Key investors in Lucy Therapeutics include Engine Ventures, Safar Partners, Engine Ventures.
Will Lucy Therapeutics IPO soon?
No public IPO plans have been announced for Lucy Therapeutics.
How can I track Lucy Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Lucy Therapeutics's shares on secondary markets.